Literature DB >> 23997503

Surgical decision making in the management of well-differentiated thyroid cancer.

Natalya Chernichenko1, Ashok R Shaha.   

Abstract

The incidence of thyroid cancer in the United States has been increasing. The biologic behavior of well-differentiated thyroid cancer (WDTC) can vary from indolent tumor to an aggressive disease with invasion of critical structures and/or widespread distant metastasis. Therefore, the risk stratification is crucial in understanding the biology of thyroid cancer, its prognosis and appropriate therapeutic interventions. In fact, understanding the nuances of biological behavior of thyroid carcinomas lays the foundation for the idea of selective surgical management of this disease.

Entities:  

Keywords:  management; well-differentiated thyroid cancer

Year:  2012        PMID: 23997503      PMCID: PMC3444581          DOI: 10.1007/s13193-012-0148-0

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  20 in total

1.  A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period.

Authors:  Iwao Sugitani; Nobukatsu Kasai; Yoshihide Fujimoto; Akio Yanagisawa
Journal:  Surgery       Date:  2004-02       Impact factor: 3.982

Review 2.  Papillary thyroid cancer: monitoring and therapy.

Authors:  R Michael Tuttle; Rébecca Leboeuf; Andrew J Martorella
Journal:  Endocrinol Metab Clin North Am       Date:  2007-09       Impact factor: 4.741

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis.

Authors:  J P Shah; T R Loree; D Dharker; E W Strong
Journal:  Am J Surg       Date:  1993-10       Impact factor: 2.565

5.  Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.

Authors:  S I Sherman; J D Brierley; M Sperling; K B Ain; S T Bigos; D S Cooper; B R Haugen; M Ho; I Klein; P W Ladenson; J Robbins; D S Ross; B Specker; T Taylor; H R Maxon
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

6.  Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study.

Authors:  S A Hundahl; B Cady; M P Cunningham; E Mazzaferri; R F McKee; J Rosai; J P Shah; A M Fremgen; A K Stewart; S Hölzer
Journal:  Cancer       Date:  2000-07-01       Impact factor: 6.860

7.  Clinicopathologic study of thyroid carcinoma infiltrating the trachea.

Authors:  T Tsumori; K Nakao; M Miyata; M Izukura; Y Monden; M Sakurai; Y Kawashima; K Nakahara
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

8.  Locally invasive papillary thyroid carcinoma: 1940-1990.

Authors:  T V McCaffrey; E J Bergstralh; I D Hay
Journal:  Head Neck       Date:  1994 Mar-Apr       Impact factor: 3.147

9.  Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.

Authors:  Ashok R Shaha
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

10.  Differentiated carcinoma of the thyroid with extrathyroidal extension.

Authors:  P E Andersen; J Kinsella; T R Loree; A R Shaha; J P Shah
Journal:  Am J Surg       Date:  1995-11       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.